07:00 , Apr 25, 2016 |  BioCentury  |  Regulation

Endangered TIGER?

Comments from an FDA panel suggest there may still be a path to market for rociletinib from Clovis Oncology Inc. in NSCLC, albeit a much narrower one. But that depends on the company taking advice...
08:00 , Dec 5, 2013 |  BC Innovations  |  Distillery Techniques

Technology: Disease models

Approach Summary Licensing status Publication and contact information Disease models Mouse model of intrahepatic cholangiocarcinoma (ICC) Orthotopic allograft mouse models of ICC could be used to validate drivers of...
08:00 , Nov 19, 2007 |  BioCentury  |  Finance

Ebb & Flow

Skyline Ventures capitalized on a string of acquisitions of portfolio companies and IPO exits over the last few years by raising a fifth fund of $350 million in only four months, almost doubling its funds...